UnitedHealth Group Inc (NYSE:UNH) CAO Thomas E. Roos sold 1,177 shares of the stock in a transaction that occurred on Thursday, November 7th. The shares were sold at an average price of $255.04, for a total transaction of $300,182.08. Following the completion of the sale, the chief accounting officer now owns 21,687 shares in the company, valued at $5,531,052.48. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

UNH stock traded up $0.51 during mid-day trading on Friday, hitting $256.97. 2,200,215 shares of the company were exchanged, compared to its average volume of 4,544,972. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.67 and a current ratio of 0.70. The firm has a market cap of $237.20 billion, a P/E ratio of 19.95, a P/E/G ratio of 1.33 and a beta of 0.61. The firm’s 50 day simple moving average is $234.76 and its 200 day simple moving average is $241.05. UnitedHealth Group Inc has a 1-year low of $208.07 and a 1-year high of $287.94.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $3.88 EPS for the quarter, topping the consensus estimate of $3.75 by $0.13. The firm had revenue of $60.35 billion for the quarter, compared to the consensus estimate of $59.84 billion. UnitedHealth Group had a net margin of 5.57% and a return on equity of 25.30%. The business’s quarterly revenue was up 6.7% on a year-over-year basis. During the same period last year, the company posted $3.41 EPS. On average, equities research analysts predict that UnitedHealth Group Inc will post 14.96 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a dividend of $1.08 per share. This represents a $4.32 annualized dividend and a yield of 1.68%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 33.54%.

A number of hedge funds have recently made changes to their positions in the business. Garrison Point Advisors LLC raised its holdings in shares of UnitedHealth Group by 1.2% in the second quarter. Garrison Point Advisors LLC now owns 3,486 shares of the healthcare conglomerate’s stock valued at $851,000 after purchasing an additional 40 shares during the last quarter. Clear Harbor Asset Management LLC grew its stake in shares of UnitedHealth Group by 0.6% in the third quarter. Clear Harbor Asset Management LLC now owns 6,573 shares of the healthcare conglomerate’s stock valued at $1,428,000 after buying an additional 40 shares in the last quarter. Smith Moore & CO. grew its stake in shares of UnitedHealth Group by 1.3% in the second quarter. Smith Moore & CO. now owns 3,156 shares of the healthcare conglomerate’s stock valued at $770,000 after buying an additional 41 shares in the last quarter. Integrated Investment Consultants LLC grew its stake in shares of UnitedHealth Group by 3.9% in the second quarter. Integrated Investment Consultants LLC now owns 1,131 shares of the healthcare conglomerate’s stock valued at $276,000 after buying an additional 42 shares in the last quarter. Finally, Meridian Financial Partners LLC grew its stake in shares of UnitedHealth Group by 2.7% in the second quarter. Meridian Financial Partners LLC now owns 1,633 shares of the healthcare conglomerate’s stock valued at $403,000 after buying an additional 43 shares in the last quarter. Hedge funds and other institutional investors own 85.66% of the company’s stock.

A number of analysts recently weighed in on the stock. Zacks Investment Research upgraded shares of UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 price target on the stock in a research report on Monday, July 22nd. Jefferies Financial Group downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and cut their price target for the company from $300.00 to $235.00 in a research report on Thursday, October 10th. Barclays set a $260.00 price target on shares of UnitedHealth Group and gave the company a “buy” rating in a research report on Tuesday, October 8th. UBS Group cut their price target on shares of UnitedHealth Group from $281.00 to $257.00 and set a “neutral” rating on the stock in a research report on Thursday, October 17th. Finally, BMO Capital Markets downgraded shares of UnitedHealth Group from an “outperform” rating to a “market perform” rating and cut their price target for the company from $292.00 to $249.00 in a research report on Monday, September 30th. Five research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus target price of $283.84.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Story: What is the cash asset ratio?

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.